183 related articles for article (PubMed ID: 16584301)
1. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility.
Kam KM; Yip CW; Cheung TL; Tang HS; Leung OC; Chan MY
Microb Drug Resist; 2006; 12(1):7-11. PubMed ID: 16584301
[TBL] [Abstract][Full Text] [Related]
2. [Induction in vitro and stability of Mycobacterium tuberculosis resistance to ofloxacin].
Yang H; Hu Z; Sha W; Lu J; Cui Z; Wang J; Huang X; Xiao H
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):318-23. PubMed ID: 24969458
[TBL] [Abstract][Full Text] [Related]
3. Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay.
Kambli P; Ajbani K; Sadani M; Nikam C; Shetty A; Udwadia Z; Rodwell TC; Catanzaro A; Rodrigues C
Tuberculosis (Edinb); 2015 Mar; 95(2):137-41. PubMed ID: 25522842
[TBL] [Abstract][Full Text] [Related]
4. gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.
Sirgel FA; Warren RM; Streicher EM; Victor TC; van Helden PD; Böttger EC
J Antimicrob Chemother; 2012 May; 67(5):1088-93. PubMed ID: 22357804
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin.
Nosova EY; Bukatina AA; Isaeva YD; Makarova MV; Galkina KY; Moroz AM
J Med Microbiol; 2013 Jan; 62(Pt 1):108-113. PubMed ID: 23019190
[TBL] [Abstract][Full Text] [Related]
6.
Tudó G; Lopez-Gavin A; Portell-Buj E; Freixes J; Vila J; Roman A; Monté MR; Gonzalez-Martin J
Microb Drug Resist; 2020 Sep; 26(9):1019-1022. PubMed ID: 32159449
[TBL] [Abstract][Full Text] [Related]
7. Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates.
Chien JY; Chiu WY; Chien ST; Chiang CJ; Yu CJ; Hsueh PR
Antimicrob Agents Chemother; 2016 Apr; 60(4):2090-6. PubMed ID: 26787695
[TBL] [Abstract][Full Text] [Related]
8. Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
Mamatha HG; Shanthi V
J Glob Antimicrob Resist; 2018 Mar; 12():5-10. PubMed ID: 28887289
[TBL] [Abstract][Full Text] [Related]
9. Genotype analysis of ofloxacin-resistant multidrug-resistant
Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
[TBL] [Abstract][Full Text] [Related]
11. Validation of the agar proportion and 2 liquid systems for testing the susceptibility of Mycobacterium tuberculosis to moxifloxacin.
Piersimoni C; Lacchini C; Penati V; Iona E; Fattorini L; Nista D; Zallocco D; Gesu GP; Codecasa L
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):283-7. PubMed ID: 17338942
[TBL] [Abstract][Full Text] [Related]
12. Performance of Sequencing in Predicting Ofloxacin Resistance in
Wang Z; Xie T; Mu C; Sun R; Wang C; Zhao H; Ju H
Ann Clin Lab Sci; 2018 Jan; 48(1):69-74. PubMed ID: 29530999
[TBL] [Abstract][Full Text] [Related]
13. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
Sulochana S; Rahman F; Paramasivan CN
J Chemother; 2005 Apr; 17(2):169-73. PubMed ID: 15920901
[TBL] [Abstract][Full Text] [Related]
15. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis.
Verma JS; Nair D; Rawat D; Manzoor N
Indian J Med Microbiol; 2011; 29(3):280-2. PubMed ID: 21860110
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.
Von Groll A; Martin A; Jureen P; Hoffner S; Vandamme P; Portaels F; Palomino JC; da Silva PA
Antimicrob Agents Chemother; 2009 Oct; 53(10):4498-500. PubMed ID: 19687244
[TBL] [Abstract][Full Text] [Related]
17. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
Mather R; Karenchak LM; Romanowski EG; Kowalski RP
Am J Ophthalmol; 2002 Apr; 133(4):463-6. PubMed ID: 11931779
[TBL] [Abstract][Full Text] [Related]
18. Ofloxacin resistance in Mycobacterium tuberculosis is associated with efflux pump activity independent of resistance pattern and genotype.
Sun Z; Xu Y; Sun Y; Liu Y; Zhang X; Huang H; Li C
Microb Drug Resist; 2014 Dec; 20(6):525-32. PubMed ID: 24940805
[TBL] [Abstract][Full Text] [Related]
19. Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.
Chien JY; Chien ST; Chiu WY; Yu CJ; Hsueh PR
Antimicrob Agents Chemother; 2016 Aug; 60(8):4708-16. PubMed ID: 27216062
[TBL] [Abstract][Full Text] [Related]
20. Impact of short-term exposure to fluoroquinolones on ofloxacin resistance in HIV-negative patients with tuberculosis.
Park IN; Hong SB; Oh YM; Lim CM; Lee SD; Lew WJ; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
Int J Tuberc Lung Dis; 2007 Mar; 11(3):319-24. PubMed ID: 17352099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
